23
Participants
Start Date
June 30, 2009
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
everolimus
New York University, New York
Memorial Sloan-Kettering Cancer Institute, New York
John Hopkins Medical Center, Baltimore
Children's Healthcare of Atlanta, Atlanta
University of Florida College of Medicine, Gainesville
The Children's Hospital, Denver
Phoenix Children's Hospital Center for Cancer and Blood Disorders, Phoenix
Doernbecher Children's Hospital Oregon Health & Science University, Portland
Seattle Cancer Care Alliance, Seattle
Dana-Farber Cancer Institute, Boston
Collaborators (1)
Novartis
INDUSTRY
Pediatric Oncology Experimental Therapeutics Investigators' Consortium
UNKNOWN
Dana-Farber Cancer Institute
OTHER